Introduction {#s1}
============

The search and discovery of novel microbes that produce new secondary metabolites can be expected to remain significant in the race against new and emerging diseases and antibiotic resistant pathogens (Berdy, [@B3]; Manivasagan et al., [@B39]). Actinomycetes are widely distributed in various marine habitats, ranging from sea sand (Hong et al., [@B23]), mangrove sediments (Hong et al., [@B22]; Hong, [@B21]; Azman et al., [@B2]), sea water (Zhang L. et al., [@B83]), coastal sediments (Yu et al., [@B80]), and deep sea sediments (Zhang et al., [@B82]; Chen et al., [@B7]). The increasing number of literature on marine actinomycetes strongly supported the view that marine environments including deep sea are significant sources for search and discovery of both diverse actinomycetes resources and secondary metabolites (Skropeta and Wei, [@B54]; Xu et al., [@B75]).

Deep sea habitats show extreme variations in available nutrients, light, oxygen concentration, pressure, salinity, and temperature. Deep-sea organisms have developed unique biochemical metabolic and physiological capabilities, which not only ensure their survival in this habitat but also provide potential for the production of novel metabolites absent in terrestrial microorganisms (Fenical, [@B12]; Bull et al., [@B6]; Skropeta and Wei, [@B54]). Through molecular ecology studies, actinobacterial operational taxonomic units (OTUs) have been identified from deep sea sediments. Most of those foreseeably exhibit novel species, genera and families (Stach and Bull, [@B58]; Chen et al., [@B7]). Diverse species of actinomycetes cultured from the deep seafloor surface, including the deepest sea sediment samples from the Mariana Trench, have shown great biosynthetic capacities and thus a potent source of novel natural products (Pathom-aree et al., [@B47]; Abdel-Mageed et al., [@B1]). With the breakthrough of technological barriers associated with deep sea actinobacteria isolation strategies, such as sample collection and cultivation under standard laboratory conditions, more and more deep sea actinobacteria and their natural products have been identified. Here we review the recent progress on deep sea actinomycetes and their metabolites from literature during year 2006--2016.

Deep sea environment and biodiversity {#s2}
=====================================

The vast oceans cover 70% of the world\'s surface, with 95% greater than 1,000 m deep. Deep sea environments are divided into the bathyal zone (depths between 200 and 2,000 m), the abyssal (depths between 2,000 and 6,000 m) and the hadal zone (depths below 6,000 m) (Harino et al., [@B19]). Below sea level pressure is increased by depth, thereby in the deepest part of the trenches, the pressure varying from 10 atm at the shelf- slope interface to \>1,000 atm. At bathyal depths temperatures taper off rapidly with increasing depth to 2°C. Deep-sea species must adjust their biochemical processes to survive in low temperatures, because the cold reduces chemical reaction rates. Oxygen concentration drops along with the depth, oxygen-minimum layer in mid-water, usually between 300 and 1,000 m depth. Light intensity decreases exponentially with depth in the water column. No photosynthetically useful light reaches the sea floor below about 250 m (Thistle, [@B60]).

Start at about 200 m depth, the deep sea is characterized by high pressure, low temperature, lack of light and variable salinity and oxygen concentration (Das et al., [@B10]), at the shelf break, where a clear change of fauna from shallow to deep water is observed (Thistle, [@B60]). According to Haefner ([@B17]), in cold deep sea mud the diversity of life can be remarkably high with species richness rivaling that of tropical rain forest. Studying the species level of microbial diversity, finding a large number of rare species which more than half of them considered as new species and more than 95% is unidentified, furthermore the expanding of biodiversity reach to the 5,000 m in depth to abyssal which the peak amount of species at the depths of 3,000 m and beyond (Skropeta, [@B53]). On earth abyssal hills are the most abundant of biomass, but on wider abyss the ecological impact of the habitat heterogeneity is largely unexplored (Durden et al., [@B11]).

Deep sea actinomycetes cultivation {#s3}
==================================

However, so far only a few actinomycetes have been isolated from deep sea. It is because of technological barriers associated with isolation strategies. Therefore, we are in the pace to develop efficient cultivation methods to recover the actinobacteria population from extreme deep sea habitats. To achieve the task, firstly collection of samples from deep sea plays a pivotal role. In recent years several advancements have been developed in the context of sample collection from deep sea such as modified sediment grab and designer-built bounce corer (Fenical and Jensen, [@B13]), remote-operated submarine vehicle (Pathom-aree et al., [@B47]), neuston sampling devices (Hakvåg et al., [@B18]), multi-core sampler (Xu et al., [@B76]), gravity or piston cores (D\'Hondt et al., [@B8]), and untethered coring device (Prieto-Davó et al., [@B49]).

It is crucial to cultivate deep sea actinomyetes under standard laboratory conditions. There are several factors that influence the isolation, such as pre-treatment of dry heat (Shin et al., [@B51]), media composition (Luo et al., [@B38]; Pan et al., [@B43]; Song et al., [@B57]), dilution factor (Pathom-aree et al., [@B44]), seawater requirement (Song et al., [@B57]), artificial seawater (Pan et al., [@B43]; Pesic et al., [@B48]) and incubation time (Song et al., [@B57]). It has also shown the addition of different antibiotics on selective media can inhibit the growth of fungal and bacterial contamination in order to enhance the actinomycetes growth similar to those used in isolation of actinomycetes from terrestrial sample. Long term freeze storage of deep sea sediment samples at −80°C has shown to prevent the growth of fast-growing bacteria which in results enhance the actinomycetes population (Ulanova and Goo, [@B65]). For the initial isolation of *Streptomyces*, cultivation temperatures have also influenced the recovery from deep sea sediment samples. Optimal growth temperature generally ranging from 25 to 30°C for successful cultivation of deep sea actinomycetes (Jeong et al., [@B28]; Luo et al., [@B38]; Pesic et al., [@B48]).

Heat pre-treatment procedures have been used effectively for the selective isolation of members of several actinomycete taxa and also inhibited growth of bacterial and fungal colonies. Moreover, actinomycete spores and hyphae are more sensitive to wet than dry heat hence relatively low temperature regimes are used to pretreat water and soil suspensions. Although heat pretreatment procedures decrease the ratio of bacteria to actinomycetes on isolation plates, the numbers of actinomycetes may also be reduced (Williams et al., [@B71]; Pathom-aree et al., [@B44],[@B45],[@B46],[@B47]). Pathom-aree et al., isolated actinomycetes from Norwegian fjord sediments support that the numbers of actinomycetes were reduced when used heat pretreatment for isolation; fewer actinomycetes were isolated on selective media inoculated with suspensions treated at 55°C as opposed to 50°C. Similarly, higher counts were generally recorded on isolation plates seeded with non-heat pretreated suspensions (Pathom-aree et al., [@B47]).

For the other method, Jensen et al., [@B27] used dry and stamp method for isolation actinomycetes from tropical Pacific Ocean and found that using this method for isolation of actinomycetes showed good recovery of 44%. In addition, Ulanova and Goo ([@B65]) found that the majority of actinomycete-like colonies were also isolated using dry stamping technique from subseafloor sediments at the Nankai and Okinawa Troughs.

Novel actinomycete species {#s4}
==========================

Novel actinomycete species isolated from deep sea environment between 2006 and 2016, have yielded an impressive array of novel species with the highest number found at depths of abyssal zone and deeper. Different media has been used by researchers (Table [1](#T1){ref-type="table"}). It is worth to be noticed that long time culturing and low temperature were employed for some of the novel isolates (Table [1](#T1){ref-type="table"}). Only one novel *Microbacterium marinum* was obtained by pretreatment at 55°C, 6 min, others were from none heat pretreated samples (Table [1](#T1){ref-type="table"}). The novel deep sea actinomycete species including 21 species under 13 genera with the maximum number from *Microbacterium* (*n* = 4), followed by *Dermacoccus* (*n* = 3), *Streptomyces* (*n* = 3) and *Verrucosispora* (*n* = 2), and one novel species for each of the other 9 genera (Table [1](#T1){ref-type="table"}).

###### 

**New actinomycetes species (***n*** = 21) isolated from deep sea environment between 2006 and 2015**.

  **Species**                                 **Region**                                               **Depth(m)**    **Culture technique**                                          **References**                                                                                           
  ------------------------------------------- -------------------------------------------------------- --------------- -------------------------------------------------------------- ------------------------------------------------------------------------------------ ------------------- ----------------------------
  *Amycolatopsis marina* sp. nov.             South China Sea                                          Not sp cified   Not specified                                                  SM1 with cycloheximide, neomycin sulfate and nystatin                                28°C for 4 weeks    Bian et al., [@B5]
  *Brevibacterium oceani* sp. nov.            Chagos Trench, Indian Ocean                              5,904           Vortex sediment suspension in 2% NaCl for 1 min                Yeast extract/peptone (YP) agar                                                      15°C for 15 days    Bhadra et al., [@B4]
  *Dermacoccus abyssi* sp. nov.               Mariana Trench (Challenger Deep)                         10, 898         Shaking sediment suspension for 30 min at 150 rpm              Raffinose-histidine agar with cycloheximide and nystatin                             28°C for 12 weeks   Pathom-aree et al., [@B44]
  *Dermacoccus barathri* sp. nov.             Mariana Trench (Challenger Deep)                         10, 898         Shaking sediment suspension for 30 min at 150 rpm              Raffinose-histidine agar with cycloheximide and nystatin                             28°C for 12 weeks   Pathom-aree et al., [@B45]
  *Dermacoccus profundi* sp. nov.             Mariana Trench (Challenger Deep)                         10, 898         Shaking sediment suspension for 30 min at 150 rpm              Raffinose-histidine agar with cycloheximide and nystatin                             28°C for 12 weeks   Pathom-aree et al., [@B45]
  *Microbacterium indicum* sp. nov.           Chagos Trench, Indian Ocean                              5,904           Vortex sediment suspension in 2% NaCl for 1 min                Yeast extract/peptone (YP) agar                                                      15°C for 15 days    Shivaji et al., [@B52]
  *Microbacterium marinum* sp. nov.           South-west Indian Ocean                                  2,800           Heated sediment suspension in a water bath at 55°C for 6 min   Modified DNB- seawater medium with nalidixic acid and nystatin                       28°C for 1 week     Zhang L. et al., [@B83]
  *Microbacterium profundi* sp. nov.          East Pacific polymetallic nodule region                  5,280           Vortex sediment suspension in sterile seawater for 15 min      Modified ZoBell medium                                                               25°C for 2 weeks    Wu et al., [@B72]
  *Microbacterium sediminis* sp. nov.         South-west Indian Ocean                                  2,327           Vortex sediment suspension in sterile seawater                 FJ sea water (50%) agar with rifampicin and potassiumdichromate                      28°C                Yu et al., [@B81]
  *Modestobacter marinus* sp. nov.            Atlantic Ocean                                           2,983           Not specified                                                  Not specified                                                                        Not specified       Xiao et al., [@B74]
  *Myceligenerans cantabricum* sp. nov.       Avile\'s Canyon in the Ca tabrian Sea, Asturias, Spain   1,500           Not specified                                                  1/3 tryptic soy agar and 1/6 M-BLEB sea water agar with cycloheximide and nystatin   28°C for 2 weeks    Vizcaíno et al., [@B67]
  *Nesterenkonia alkaliphila* sp. nov.        Western Pacific Ocean                                    7,118           Not specified                                                  Modified ISP 1- seawater                                                             28°C for 3 weeks    Zhang et al., [@B82]
  *Pseudonocardia antitumoralis* sp. nov.     South China Sea                                          3,258           Not specified                                                  ISP 5- seawater medium                                                               28°C for 3 weeks    Tian et al., [@B61]
  *Sciscionella marina* gen. nov., sp. nov.   Northern South China Sea                                 516             Not specified                                                  Gauze No. 1 -seawater medium                                                         28°C for 3 weeks    Tian et al., [@B64]
  *Serinicoccus profundi* sp. nov.            Indian Ocean                                             5,368           Not specified                                                  Oligotrophic- seawater medium                                                        Not specified       Xiao et al., [@B73]
  *Streptomyces indicus* sp. nov.             Indian Ocean                                             2,434           Not specified                                                  Modified HV---sea water (75%) medium                                                 25°C                Luo et al., [@B38]
  *Streptomyces nanhaiensis* sp. nov.         South China Sea                                          1,632           Not specified                                                  Humic acid-vitamin- sea water (70%) medium                                           28°C for 3 weeks    Tian et al., [@B62]
  *Streptomyces oceani* sp. nov.              Northern South China Sea                                 578             Not specified                                                  10 % Nutrient seawater agar                                                          28°C for 3 weeks    Tian et al., [@B63]
  *Verrucosispora maris* sp. nov.             Sea of Japan                                             Not specified   Not specified                                                  Colloidal chitin agar                                                                30°C for 4 weeks    Goodfellow et al., [@B16]
  *Verrucosispora sediminis* sp. nov.         South China Sea                                          3,602           Not specified                                                  Gauze No. 1 medium                                                                   22°C for 4 weeks    Dai et al., [@B9]
  *Williamsia marianensis* sp. nov.           Mariana Trench (Challenger Deep)                         10, 898         Shaking sediment suspension for 30 min at 150 rpm              Raffinose-histidine agar with cycloheximide and nystatin                             28°C for 12 weeks   Pathom-aree et al., [@B46]

**SM1^\*^**: yeast nitrogen base (67.0 g; Difco) and casamino acids (100 mg; Difco) are added to a liter of distilled water and the solution sterilized using cellulose filters (0.20 mm) prior to the addition of sterilized dipotassium hydrogen phosphate (200 ml; 10%,w/v);100 ml of this basal medium was added to 900 ml of sterilized molten agar (1.5%,w/v) followed by filter ster l sed solutions of D (−) sorbitol (final concentration 1%,w/v); **YP agar^\*^** per liter distilled water: 5 g, yeast extract, 10 g peptone, 30 g NaCl, 15 g agar; **Raffinose-h st d ne agar^\*^**: Raffinose 10 g, L-histidine 1 g, MgSO~4~ 7H~2~O 0.5 g, FeSO~4~ 7H~2~O 0.01g, K~2~HPO~4~ 1 g, Agar 20 g, pH 7.0-7.4; **Modified DNB medium^\*^**: 0.1 g p ptone, 0.05 g b f xtract, 0.05 g NaCl, 1000 mL artificial seawater, pH 7.5; **Modified ZoBell agar^\*^**: 19.45 g NaCl, 8.8 g MgCl~2~, 3.24 g Na~2~SO~4~, 1.8 g CaCl ~2~, 0.55 g KCl, 0.16 g NaHCO~3~, 0.1 g f rric citrate pentahydrate, 80 mg KBr, 34 mg CsCl~2~, 22 mg H~3~BO~3~, 4.0 mg Na~2~SiO~3~, 2.4 mg NaF, 1.6 mg, NH~4~NO~3~, 8.0 mg Na ~3~PO~4~, 0.5 g p pton, 0.1 g yeast extract, 20 g agar (pH 5.5, adjusted with HCl); **FJ agar^\*^**: 1% glucose, 1% yeast extract, 1.5% agar, 50% seawater; **1/3 tryptic soy agar and 1/6 M-BLEB^\*^:** 1/3 tryptic soy agar (TSA, Merck) and 1/6 M-BLEB \[9 g MOPS BLEB base (Oxoid) in 1 l Cantabrian Sea water\], agar; **Modified SP 1^\*^:** (1 L atural seawate, pH 10 final): 10 g glucose, 5 g peptone, 5 g yeast extract, 0.2 g MgSO~4~. 7H~2~O, 10 g NaHCO~3~, 27 g Na~2~ CO~3~ 10H~2~O and 15 g agar; **ISP 5 medium^\*^**: L-asparagine (anhydrous basis) 1.0 g, Glycerol 10.0 g, K~2~HP0~4~ (anhydrous basis) 1.0 g, natural seawater 1. 0 l, Trace salts solution 1.0 ml Agar 20.0 g; **SM3^\*^:** glucose 10 g, peptone 5 g, tryptone 3 g, NaCl 5 g, agar 15 g, distilled water, 1 l, pH 7.0; **Gauze No. 1 medium^\*^**: Soluble starch 20.0 g, KNO~3~ 1.0 g, NaCl 0.5 g, MgSO~4~ x 7 H~2~O 0.5 g, K~2~HPO~4~ 0.5 g, FeSO~4~ x 7 H~2~O 10.0 mg, Agar 15.0 g, Sea water 1.0 L, Adjust pH 7.4; **Oligotrophic- seawater medium^\*^:** Oligotrophic medium (seawater, 2.0% agar); **Modified HV medium^\*^**: humic acid 1.0 g, KCl 1.7 g, FeSO~4~. 7H~2~O 0.01 g, Na~2~HPO~4~ 0.5 g, MgSO~4~. 7H~2~O 0.5 g, CaCO~3~ 0.02 g, thiamine 0.5 mg, nicotinic acid 0.5 mg, pantothenic acid 0.5 mg, p-aminobenzoic acid 0.5 mg, riboflavin 0.5 mg, vitamin B6 0.5 mg, inositol 0.5 mg, biotin 0.25 mg, water 250 ml, seawater 750 ml, agar 18 g, pH 7.2; **Humic acid-vitamin agar**^\*^: Humic acid 2g, Asparagine 1 g, K~2~HPO~4~ 0.5 g, FeSO~4~ 7H~2~O 0.5 g, Agar 20 g, Sea-water 1000 ml, pH 7.0--7.4; **10% Nutrient agar^\*^**: Beef extract 0.03 g, peptone 0.05 g, agar 15 g, sea water 1 L; **colloidal chitin agar^\*^**: 4 g of chitin, K~2~HPO~4~ (0.7 g); KH~2~PO, (0.3 g); MgSO~4~-5H~2~O (0.5 g); FeSO~4~.7H20 (0.01 g); ZnSO~4~ (0.001 g); MnCl~1~, (0.001 g); and 20 g of agar. pH 8.0

Natural products synthesized by deep sea actinomycetes {#s5}
======================================================

The numbers of novel microbial metabolites from deep sea sediment samples have been increasing, especially from deep sea streptomycetes. Eight genera of actinomycetes were reported to produce secondary metabolites, among which *Streptomyces* is the richest producer (Table [2](#T2){ref-type="table"}). Earlier culture dependent studies strongly suggested that *Streptomyces* species are present in considerable number in deep sea sediment samples (Jensen et al., [@B27]; Pathom-aree et al., [@B47]). In addition several novel species of deep sea derived *Streptomyces* strains with distinct metabolites have been reported which indicates deep sea *Streptomyces* are really worth in the context of novel natural products discovery (Pan et al., [@B42]; Song et al., [@B57]).

###### 

**Natural products synthesized by deep sea actinomycetes**.

  **Strain**                                **Compounds**                                                    **Region**                         **Depth (m)**   **Bioactivity**                                                          **References**
  ----------------------------------------- ---------------------------------------------------------------- ---------------------------------- --------------- ------------------------------------------------------------------------ ------------------------------------------------
  *Dermacoccus abyssi*                      Dermacozines A--G                                                Mariana Trench (Challenger Deep)   10, 898         Moderate cytotoxic activity against the leukemia cell line K562          Abdel-Mageed et al., [@B1]
  *Dermacoccus abyssi*                      Dermacozines H-J                                                 Mariana Trench (Challenger Deep)   10, 898         Radical scavenging activity                                              Wagner et al., [@B68]
  *Marinactinospora thermotolerans*         Marinacarbolines A--D, Indolactam alkaloids                      South China Sea                    3,865           Strong antiplasmodial activity                                           Huang et al., [@B25]
  *Microbacterium sediminis* sp.nov.        Microbacterins A and B                                           South-west Indian Ocean            2,327           Significatnt inhibitory effects against a panel of human tumor cell      Liu D. et al., [@B34]
  *Micromonospora* sp.                      Levantilides A and B                                             Mediterranean                      4,400           Anticancer                                                               Gärtner et al., [@B14]
  *Nocardiopsis alba* SCSIO 03039           Methoxyneihumicin                                                Indian Ocean                       Not specified   Anticancer                                                               Zhang et al., [@B84]
  *Nocardiopsis* sp.                        Nocardiopsins A and B                                            Coast of Brisbane, Australia       55              No activity                                                              Raju et al., [@B50]
  *Pseudonocardia* sp.                      Pseudonocardians A--C                                            South China Sea                    3,258           Anticancer, antibacterial activity                                       Li et al., [@B31]
  *Serinicoccus profundi* sp. nov.          Indole alkaloid                                                  Indian Ocean                       5,368           Antibacterial activity                                                   Yang et al., [@B78]
  *Streptomyces cavourensis* NA4            Bafilomycins B1 and C1                                           South China Sea                    1,464           Antifungal Substances                                                    Pan et al., [@B42]
  *Streptomyces drozdowiczii* SCSIO 10141   Marformycins                                                     South China Sea                    1,396           Anti- infective                                                          Zhou et al., [@B88]
  *Streptomyces fungicidicus*               Diketopiperazines                                                Western Pacific                    5,000           Antifouling products                                                     Li et al., [@B33]
  *Streptomyces lusitanus*                  Grincamycins B--F                                                South China Sea                    3,370           Anticancer                                                               Huang et al., [@B24]
  *Streptomyces niveus* SCSIO 3406          Marfuraquinocins                                                 South China Sea                    3,536           Cytotoxic, antibacterial activity                                        Song et al., [@B55]
  *Streptomyces olivaceus* FXJ8.012         Tetroazolemycins A and B                                         Southwest Indian Ocean             Not specified   Metal ion-binding activity                                               Liu et al., [@B36]
  *Streptomyces scopuliridis* SCSIO ZJ46    D sotamides B−D                                                  South China Sea                    3,536           Antibacterial activity                                                   Song et al., [@B56]
  *Streptomyces* sp.                        Ammosamides A and B                                              Bahamas                            1,618           Anticancer                                                               Gaudêncio et al., [@B15]
  *Streptomyces* sp.                        Benzoxacystol                                                    Atlantic                           3,814           Inhibitory activity against the enzyme glycogen synthase kinase-3b       Nachtigall et al., [@B40]
  *Streptomyces* sp.                        Caboxamycin                                                      Atlantic                           3,814           Inhibitory activity against Gram-positive bacteria, anticancer           Hohmann et al., [@B20]
  *Streptomyces* sp.                        Spiroindimicins A--D                                             Indian Ocean                       3,412           Anticancer                                                               Zhang W. J. et al., [@B85]
  *Streptomyces* sp.                        Streptokordin                                                    Ayu Trough                         Not specified   Anticancer                                                               Jeong et al., [@B28]
  *Streptomyces* sp.                        Streptopyrrolidine                                               Ayu Trough                         Not specified   Anti-angiogenesis activity                                               Shin et al., [@B51]
  *Streptomyces* sp. ACT232                 Ahpatinin                                                        Sagami Bay                         1, 174          Aspartic protease inhibitors                                             Sun et al., [@B59]
  *Streptomyces* sp. SCSIO 01127            Lobophorins E and F                                              South China Sea                    1, 350          Antibacterial activity, cytotoxicity                                     Niu et al., [@B41]
  *Streptomyces* sp. SCSIO 03032            Heronamides D−F                                                  Indian Ocean                       3,412           No activity                                                              Zhang W. et al., [@B87]
  *Streptomyces* sp. SCSIO 03032            Indimicins                                                       Indian Ocean                       3,412           Cytotoxic                                                                Zhang W. J. et al., [@B86]
  *Streptomyces* sp. SCSIO 04496            (6R,3Z)-3-benzylidene-6-isobutyl-1-methyl piperazine-2,5-dione   South China Sea                    3,536           No activity                                                              Luo et al., [@B37]
  *Streptomyces* sp. SCSIO 10355            Strepsesquitriol                                                 Indian Ocean                       3,412           Inhibitory activity against lipopolysaccharide-induced TNFα production   Yang et al., [@B77]
  *Streptomyces* sp. SCSIO 11594            Dehydroxyaquayamycin                                             South China Sea                    2,403           Antibacterial activity                                                   Song et al., [@B57]
  *Streptomyces* sp. SCSIO 11594            Marangucycline B                                                 South China Sea                    2,403           Anticancer                                                               Song et al., [@B57]
  *Streptomyces* sp. SNJ013                 Sungsanpin                                                       Jeju Island                        138             Inhibitory activity to A549 with cell invasion assay                     Um et al., [@B66]
  *Streptomyces* sp. UST040711-290          12-methyltetradecanoid acid (12-MTA)                             Pacific                            5,774           Antifouling                                                              Xu et al., [@B76]
  *Streptomyces* sp. TP-A0873               Butenolids                                                       Toyama Bay                         Not specified   Peroxisome proliferator activated receptor---PPARα agonistic             Igarashi et al., [@B26]; Komaki et al., [@B29]
  *Streptomyces* sp. 12A35                  Lobophorins H and I                                              South China Sea                    2,134           Antibacterial activity                                                   Pan et al., [@B43]
  *Streptomyces* strain C42                 Champacyclin                                                     Baltic Sea                         241             Antimicrobial activity                                                   Pesic et al., [@B48]
  *Streptomyces xiamenensis* M1-94P         Xiamenmycin C and D                                              Pacific Ocean                      2,628           Anti-fibrotic                                                            You et al., [@B79]
  *Verrucosispora* sp.                      Abyssomicins J--L                                                South China Sea                    2,733           Antibacterial activity                                                   Wang et al., [@B69]

The deepest sea sediment samples from the Mariana Trench have been shown to possess great biosynthetic capacities. Seven dermacozines A--G were reported from the actinobacteria *Dermacoccus abyssi* sp. nov., strains MT1.1 and MT1.2 isolated from Mariana Trench sediment collected at a depth of 10 898 m. Dermacozines F and G displayed moderate cytotoxic activity against the leukemia cell line K562 with IC~50~ values of 9 and 7 mM, respectively, whereas dermacozine C also exhibited high radical scavenger activity with an IC~50~ value of 8.4 mM (Abdel-Mageed et al., [@B1]).

In recent years, South China Sea has been emerging as a potentially abundant source of novel species/genera of marine actinomycetes. Some bioactive compounds, such as pseudonocardians A-C, grincamycins B-F, and abyssomicins J-L were reported. Natural products derived from deep sea actinomycetes discovery have displayed a wide range of bioactivities, such as antitumor, antimicrobial, antifouling, and anti-fibrotic activities (Table [2](#T2){ref-type="table"}).

Biosynthesis pathways for deep sea streptomycetes natural products {#s6}
==================================================================

Lobophorins H and I together with three known analogs, *O*-β-kijanosyl-(1 → 17)-kijanolide, lobophorins B and F were yielded by *Streptomyces* sp. 12A35, isolated from a deep sea sediment sample collected at a depth of 2,134 m in South China Sea (Pan et al., [@B43]). While, lobophorins E and F, along with two known analogs lobophorins A and B were discovered from the products of the deep sea *Streptomyces* sp. SCSIO 01127, was isolated from sample collected at a depth of 1,350 m in the South China Sea (Niu et al., [@B41]). The gene cluster involved in biosynthesis of lobophorin was the first type I PKS gene cluster identified from the deep sea derived *Streptomyces*. Three glycosyltransferases (GTs) LobG1-LobG3 genes-inactivation mutants yielded five different glycosylated metabolites, and the result suggested that LobG3 as an iterative GT to attach two L-digitoxoses (Li et al., [@B32]). Desotamides B, C and D together with a known desotamide A were obtained from deep sea derived *Streptomyces scopuliridis* SCSIO ZJ46, recovered from sediment sample collected at a depth of 3,536 m in the South China Sea (Song et al., [@B56]). A 39 kb gene cluster governing the biosynthesis of the anti-infective desotamides has been isolated from the strain. Desotamides A and B and a new desotamide G have been obtained by heterologous expression of desotamide gene cluster in *Streptomyces coelicolor* M1152 (Li et al., [@B30]).

Heronamides D, E, and Fare discovered from the products of *Streptomyces* sp. SCSIO 03032, which was isolated from deep sea sediment sample collected at a depth of 3,412 m in the Bay of Bengal, Indian Ocean (Zhang W. et al., [@B87]). The gene cluster governing the biosynthesis of heronamide has been isolated from strain SCSIO 03032. The gene inactivation study confirmed that P450 enzyme encode HerO as an 8-hydroxylase for tailoring heronamide biosynthesis. Feeding experiments with labeled small carboxylic acid molecules confirmed the migrated double bonds in the conjugated diene-containing side chain of heronamides (Zhu et al., [@B89]).

Marformycins A-F were obtained from fermentation broth of deep sea sediment-derived *Streptomyces drozdowiczii* SCSIO 1014, which was isolated from sample collected at a depth of 1,396 m in South China Sea. All compounds exerted selective anti-microbial activity against *Micrococcus luteus, Propionibacterium acnes*, and *P. granulosum*. Marformycins A-E displayed inhibitory activity against *M. luteus* with MICs of 0.25, 4.0, 0.25, 0.063, and 4.0 μg/mL, respectively, while they did not displayed any cytotoxicity (Liu D. et al., [@B34]). It is suggested that these compounds may be used as promising candidatures for anti-infective drug leads. The gene cluster that responsible for the biosynthesis of marformycin is about 45 kb in size and has been identified from strain SCSIO 10141. The gene inactivation studies indicated that three NRPS proteins MfnC, MfnD, MfnE, a free adenylation (A) enzyme MfnK, and a free peptidyl carrier protein (PCP) MfnL were essential for the generation of the marformycin core scaffold. Further, MfnN was found to use an intact cyclodepsipeptide intermediate as its substrate (Liu J. et al., [@B35]).

Perspective {#s7}
===========

The discovery of novel actinomycete taxa with unique metabolic activity from deep sea samples, and novel compounds with the greatest biogenic, metabolic diversity and biological activities clearly illustrate that indigenous deep sea actinomycetes indeed exist in the oceans and are an important source of novel secondary metabolites. Other function of deep sea actinobacteria is also interesting such as oil degradation and biosurfactant production (Wang et al., [@B70]). It is worth to be noticed that no heat pretreatment, dry and stamp method and low temperature incubation were more productive for actinomycetes isolation from some deep sea samples. With the development of culture independent techniques, more productive strategy of strain isolation guided by the deep sea actinomycetes distribution or direct cloning and heterologous express the functional genes could be approached.
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